Penile Cancer—Novel Translational and Clinical Insights

Dear Colleagues,

Notwithstanding the great efforts to better understand and characterize the disease as well as improve patient outcomes, successful individualized management of penile cancer is still challenging. In particular, the response rate to available systemic treatment as well as the survival of metastasized patients has remained unchanged for a long time. Obviously, the rarity of penile cancer creates a diagnostic and therapeutic challenge for physicians. The lack of high-level evidence frequently results in a limited guideline adherence and outcomes, especially in nonspecialized centres. Of note, clinical studies are scarce due to the rarity of this condition and the subsequent shortcoming of the support by the pharmaceutical industry and other third parties. In concert, fund raising for translational research is intricate, resulting in a lack of biomarker and targeted therapy candidates, available cell cultures, and xenograft models.

The Special Issue of the Journal of Clinical Medicine entitled “Penile Cancer—Novel Translational and Clinical Insights” is aimed at illuminating of the current outstanding preclinical and clinical research presenting cutting-edge findings in the whole area of this demanding yet intriguing condition. Original as well as review manuscripts of the highest quality are welcomed for submission.

Prof. Dr. Igor Tsaur
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.